Market Access Biosimilar switches and healthcare gains Despite being used across Europe for more than a decade, biosimilar medications are still something of a mystery among those outside the sector.
News Novartis freezes drug prices in a nod to Trump Novartis has announced it would not raise drug prices in the US this year, while Merck & Co announced huge cuts in the price of its hepatitis drug following pressure from president Trum
News AZ suffers setback as NICE slaps restrictions on Fasenra Fasenra can only be used after GSK rival, NICE says in draft decision
News NHS does not value CF patients, says Vertex CEO in letter to... But Vertex dismisses rumours it will quit the UK
News NHS England okays funding for cholesterol-lowering drug Lojuxta will be available to patients this year
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.